Renal Denervation System Receives EU Green Light
Published date : 05 February 2013
Article date : 05 February 2013
Medgadget reports that ReCor Medical, manufacturers of the ultrasound based renal denervation system for control of hypertension has received clearance for its PARADISE Gen 2 device from EU authorities. The original system was approved for sale a year ago and the new system provides an over-the-wire 6Fr device size and faster denervation.
“Our unique approach is in stark contrast to RF, which is limited in its depth of penetration to just a few millimeters, due to inconsistent arterial wall contact, as well as its inability to heat circumferentially in any given location,” said Iyer. “In addition, RF technologies generate unnecessary heating at the level of the arterial wall. Data presented at TCT 2012 concluded that renal nerves are actually much further at depth than previously thought, and run circumferentially around the renal arteries, which underscores the PARADISE ultrasound advantage.”
Source: Gene Ostrovsky, Medgdget, 29 January 2013
